|
HY-P78206-50ug
|
MedChemexpress LLC
|
Siglec-10, Human (Biotinylated, R119A, HEK293, His-Avi)
|
|
|
|
|
HY-P72476-10ug
|
MedChemexpress LLC
|
Siglec-10, Human (HEK293, Fc)
|
|
|
|
|
HY-P72476-5ug
|
MedChemexpress LLC
|
Siglec-10, Human (HEK293, Fc)
|
|
|
|
|
HY-P72476-50ug
|
MedChemexpress LLC
|
Siglec-10, Human (HEK293, Fc)
|
|
|
|
|
HY-P78514-20ug
|
MedChemexpress LLC
|
Siglec-10, Human (R119A, HEK293, His-Avi)
|
|
|
|
|
HY-P78514-50ug
|
MedChemexpress LLC
|
Siglec-10, Human (R119A, HEK293, His-Avi)
|
|
|
|
|
HY-W009732-1g
|
MedChemexpress LLC
|
Sinapinic acid [CAS 530-59-6]
|
|
Cancer-programmed cell death
|
|
|
HY-W009732-1mL
|
MedChemexpress LLC
|
Sinapinic acid [CAS 530-59-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-107625A-10mg
|
MedChemexpress LLC
|
SNAP 94847 (hydrochloride) [CAS 1781934-47-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107625A-100mg
|
MedChemexpress LLC
|
SNAP 94847 (hydrochloride) [CAS 1781934-47-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107625A-25mg
|
MedChemexpress LLC
|
SNAP 94847 (hydrochloride) [CAS 1781934-47-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107625A-5mg
|
MedChemexpress LLC
|
SNAP 94847 (hydrochloride) [CAS 1781934-47-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107625A-50mg
|
MedChemexpress LLC
|
SNAP 94847 (hydrochloride) [CAS 1781934-47-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107625A-1mL
|
MedChemexpress LLC
|
SNAP 94847 (hydrochloride) [CAS 1781934-47-1] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N0339-100mg
|
MedChemexpress LLC
|
Syringic acid [CAS 530-57-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N0339-1mL
|
MedChemexpress LLC
|
Syringic acid [CAS 530-57-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N6654-250mg
|
MedChemexpress LLC
|
Syringyl Alcohol [CAS 530-56-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6654-1mL
|
MedChemexpress LLC
|
Syringyl Alcohol [CAS 530-56-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-109124A-10mg
|
MedChemexpress LLC
|
Taniborbactam (hydrochloride) [CAS 2244235-49-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-109124A-5mg
|
MedChemexpress LLC
|
Taniborbactam (hydrochloride) [CAS 2244235-49-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-109124A-50mg
|
MedChemexpress LLC
|
Taniborbactam (hydrochloride) [CAS 2244235-49-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1677-100mg
|
MedChemexpress LLC
|
2,6-Dimethoxy-1,4-benzoquinone [CAS 530-55-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-N1677-50mg
|
MedChemexpress LLC
|
2,6-Dimethoxy-1,4-benzoquinone [CAS 530-55-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P1005-1mg
|
MedChemexpress LLC
|
Ac-DEVD-AFC [CAS 201608-14-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P1005-10mg
|
MedChemexpress LLC
|
Ac-DEVD-AFC [CAS 201608-14-2]
|
|
Cancer-programmed cell death
|
|
